Aortic Valve Disease: Clinical Trials

1,638 trials for Aortic Valve Disease, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

667 completed, 302 unknown, 292 recruiting, 120 active not recruiting. 629 Not applicable, 81 Phase 4, 79 Phase 2, 70 Phase 3, 26 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable629Completed 242, Unknown 108, Recruiting 100, Active not recruiting 59, Not yet recruiting 46, Terminated 43, Withdrawn 19, Enrolling by invitation 11, Suspended 1
Phase 481Completed 27, Unknown 22, Recruiting 14, Terminated 8, Not yet recruiting 6, Active not recruiting 1, Enrolling by invitation 1, Suspended 1, Withdrawn 1
Phase 279Completed 35, Unknown 15, Recruiting 11, Terminated 6, Active not recruiting 4, Not yet recruiting 4, Withdrawn 3, Enrolling by invitation 1
Phase 370Completed 31, Unknown 12, Terminated 8, Recruiting 7, Active not recruiting 6, Not yet recruiting 3, Withdrawn 2, Enrolling by invitation 1
Phase 126Completed 19, Recruiting 3, Unknown 3, Terminated 1
Early Phase 15Completed 3, Not yet recruiting 1, Withdrawn 1

Follow Aortic Valve Disease: new trials by email Literature Review of Aortic Valve Disease trials Research Report on Aortic Valve Disease

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Aficamten and Patient-Reported Outcomes in Real-World nHCM
receiving aficamten - Hypertrophic Cardiomyopathy (HCM)
Not yet recruitingSecond Affiliated Hospital, Zhejiang University, School of Medicine1002027-06-012026-09-29
Evaluation of a Management Algorithm for TAVI Patients With Concomitant Mitral or Tricuspid Regurgitation
Aortic Stenosis, Mitral Regurgitation
Not yet recruitingJosep Rodes-Cabau3002027-01-052026-11-04
High Flow Nasal Oxygenation in Transcatheter Aortic Valve Replacement Procedures. TAVR-Highflow II
Oxygen therapy during sedation provided via high nasal cannulae (60L/min at 60% FiO2), Oxygen therapy during sedation delivered via nasal cannulae at 5L/min - Aortic Stenosis Treated With TAVI, Sedation; Aged; Hemodynamics
Not applicableNot yet recruitingHospital Clinic of Barcelona4522027-01-012026-09-18
Importance of Point-of-Care Ultrasound for Early Detection of Valvular and Cardiac Diseases (IMPROVE)
Kosmos Torso-One AI-guided Point-of-Care Ultrasound (EchoNous, Inc.) - Valvular Heart Disease Patients, Aortic Stenosis
Not applicableNot yet recruitingUniversity of Texas Southwestern Medical Center10882026-12-152026-11-03
A Prospective, Multi-centre, Single Arm, Pivotal Clinical Study to Determine the Safety and Effectiveness of Crea Aortic Valve for Use as a Replacement Aortic Heart Valve
Investigational Transcatheter Aortic Valve Replacement System - Aortic Valve Stenosis, Severe Aortic Stenosis
Not applicableNot yet recruitingOnecrea Medical Inc.302026-12-042026-07-29
Gradual Tapering or Discontinuation of Beta-Blockers After Stabilization With Mavacamten Therapy
Beta-Blocker Sequential Tapering and Discontinuation, Beta-Blocker Baseline Stable-Dose Maintenance - Obstructive Hypertrophic Cardiomyopathy (oHCM)
Not applicableNot yet recruitingFirst Affiliated Hospital of Wenzhou Medical University2862026-12-012026-09-11
Regression in Left Ventricular Hypertrophy and Fibrosis in Aortic Stenosis
Dapagliflozin (DAPA), Spironolactone (drug), Spironolactone + Dapagliflozin - Aortic Stenosis
Phase 2Not yet recruitingUniversity College, London4452026-12-012026-09-11
Effect of Double-Tap Optimization on Valve Expansion and Hemodynamics in Balloon-expandable Transcatheter Aortic Valve Implantation: A Randomized Clinical Trial (DO-OPT TAVI Trial)
Double-Tap Balloon Post-dilatation, Conventional Single-Inflation TAVI - Severe Aortic Stenosis
Not applicableNot yet recruitingYonsei University2502026-12-012026-11-03
Application of TAVI at Experienced Interventional Cardiac Centers Without On-site Cardiac Surgery (ATLAS Study)
Transcatheter Aortic Valve Replacement (TAVR) with surgical oversight, Transcatheter Aortic Valve Replacement (TAVR) without surgical oversight - Aortic Stenosis, Severe Aortic Stenosis
Phase 4Not yet recruitingUniversity of Alberta6002026-12-012026-10-27
Sparrow App Guided Evaluation (SAGE) Vanguard Trial for Aortic Stenosis in Adults Aged Seventy and Older
Stethophone - Moderate or Severe Aortic Stenosis
Not applicableNot yet recruitingSunnybrook Health Sciences Centre10002026-12-012026-11-12
NHLBI SESAME (SEptal Scoring Along Midline Endocardium) Multi-Center Prospective Study Using Improvised Off-Label Devices
SESAME Procedure - Hypertrophic Cardiomyopathy, Left Ventricular Outflow Obstruction
Not applicableNot yet recruitingNational Heart, Lung, and Blood Institute (NHLBI)2002026-11-172026-11-12
Human Experimental Models of Pain (HEMP)
Placebo, Naproxen, Pregabalin - Acute Pain
Not applicableNot yet recruitingNational Center for Complementary and Integrative Health (NCCIH)252026-11-172026-11-12
Exercise and Diet Supplements for Older Patients Undergoing TAVI: the IRON-TAVI Trial
Personalized Multidomain Exercise Program, Oral Protein and Iron Nutritional Supplementation, Usual Care - Aortic Stenosis Disease, Aortic Stenosis Symptomatic
Not applicableRecruitingUniversity Hospital of Ferrara4502026-11-042026-11-05
Safety and Clinical Performance of the Next-Generation SAFESYNC Transcatheter Heart Valve in Patients With Severe Aortic Stenosis
INOVARE® SAFESYNC Next-Generation Bioprosthetic Heart Valve - Aortic Stenosis Senile, Aortic Stenosis Symptomatic
Not applicableNot yet recruitingBraile Biomedica Ind. Com. e Repr. Ltda.402026-11-012026-09-08
Efficacy and Safety of an LVEF-Guided Mavacamten Dose Up-Titration Strategy in Chinese Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy
Mavacamten - Obstructive Hypertrophic Cardiomyopathy (oHCM)
Phase 4Not yet recruitingSecond Affiliated Hospital of Nanchang University1152026-11-012026-11-12
Prospective Multicenter Study Evaluating Myval TAVR Safety and Effectiveness in High-risk Severe AR
Myval THV series - Aortic Regurgitation, Aortic Disease
Not applicableNot yet recruitingCeric Sàrl1642026-10-302026-08-07
Balloon- Versus Self-Expanding Intraannular TAVI in Small Aortic Annuli
Meril Octapro+ THV System, Abbott Navitor/Navitor Vision THV system - Aortic Valve Stenosis
Not applicableNot yet recruitingUniversitätsklinikum Hamburg-Eppendorf5102026-10-262026-08-31
SYMmetric Valve fraME Expansion To Reduce hYpoattenuated Leaflet Thickening After Balloon-expandable TAVI: the SYMMETRY Trial
Double-TAP post-dilatation - Aortic Valve Stenosis and/or Insufficiency, Hypoattenuated Leaflet Thickening
Not applicableRecruitingErasmus Medical Center4222026-10-262026-10-30
Systematic Ambulatory ECG Monitoring Following TAVI
Ambulatory ECG monitoring - Aortic Stenosis, Conduction Disturbances
Not applicableRecruitingInstitut universitaire de cardiologie et de pneumologie de Québec, University Laval7542026-10-232026-11-04
Aom0304 in Adult Patients With Symptomatic Hypertrophic Cardiomyopathy
QG101-23-0 enteric coated capsule (60/120/240/360 mg BID), QG101-23-0 enteric coated capsule (120/240/360/480mg BID) - Hypertrophic Cardiomyopathy (HCM), Obstructive HCM (oHCM)
Phase 2Not yet recruitingAmckaus PTY LTD.562026-10-012026-06-30

Showing 20 of 1638. Sign in to see all of them.

Narrower conditions

Aortic Valve Stenosis (991)  ·  Cardiomyopathy, Hypertrophic (353)  ·  Aortic Valve Insufficiency (165)  ·  Heart Valve Diseases (109)  ·  Coronary Artery Disease (78)  ·  Cardiovascular Diseases (65)  ·  Bicuspid Aortic Valve Disease (62)  ·  Heart Failure (62)  ·  Mitral Valve Insufficiency (56)  ·  Heart Diseases (48)  ·  Cardiomyopathy, Dilated (39)  ·  Aortic Valve, Calcification of (36)  ·  Cardiomyopathies (33)  ·  Hypertrophy, Left Ventricular (30)

Broader conditions

Heart Diseases (1590)  ·  Cardiovascular Diseases (1573)  ·  Heart Valve Diseases (1529)  ·  Ventricular Outflow Obstruction (1007)  ·  Aortic Valve Stenosis (386)  ·  Aortic Stenosis, Subvalvular (354)  ·  Cardiomyopathies (326)  ·  Pathological Conditions, Signs and Symptoms (254)  ·  Vascular Diseases (221)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (195)  ·  Pathologic Processes (167)  ·  Congenital Abnormalities (133)  ·  Genetic Diseases, Inborn (112)  ·  Cardiovascular Abnormalities (111)

Interventions

Transcatheter Aortic Valve Replacement (155)  ·  MYK-461 (37)  ·  Echocardiography (22)  ·  Aspirin (14)  ·  Exercise (13)  ·  Clopidogrel (12)  ·  Blood Specimen Collection (8)  ·  Standard of Care (8)  ·  Hematologic Tests (7)  ·  Magnetic Resonance Imaging (7)  ·  Magnetic Resonance Spectroscopy (7)  ·  Saline Solution (7)  ·  Anesthesia, Local (6)  ·  Electrocardiography, Ambulatory (6)  ·  Losartan (6)

Sponsors

Edwards Lifesciences (45)  ·  National Heart, Lung, and Blood Institute (NHLBI) (38)  ·  Abbott Medical Devices (31)  ·  Bristol-Myers Squibb (25)  ·  Medtronic Cardiovascular (18)  ·  Xijing Hospital (18)  ·  University Hospital, Montpellier (17)  ·  Boston Scientific Corporation (16)  ·  China National Center for Cardiovascular Diseases (16)  ·  Institut für Pharmakologie und Präventive Medizin (16)  ·  Assistance Publique - Hôpitaux de Paris (15)  ·  Second Affiliated Hospital, Zhejiang University, School of Medicine (15)  ·  Chinese Academy of Medical Sciences, Fuwai Hospital (14)  ·  Oslo University Hospital (14)  ·  The Cleveland Clinic (14)

Countries

United States (381)  ·  Germany (233)  ·  France (186)  ·  United Kingdom (168)  ·  Italy (164)  ·  China (160)  ·  Netherlands (133)  ·  Canada (123)  ·  Spain (104)  ·  Denmark (87)  ·  Switzerland (74)  ·  Belgium (62)  ·  Austria (51)  ·  Poland (46)  ·  Sweden (46)

Top investigators

Hendrik Treede, MD (7)  ·  Martin B Leon, MD (6)  ·  John Webb, MD (5)  ·  Michael Reardon, MD (5)  ·  Robert J Lederman, M.D. (5)  ·  Barathi Sethuraman (4)  ·  Manfred Boehm, M.D. (4)  ·  Raj Makkar, MD (4)  ·  Seung-jung Park, MD (4)  ·  Vinod Thourani, MD (4)  ·  Alibek Kh Mustafin, Professor (3)

Results publications

PMID 20961243, PMID 33962483, PMID 21639811, PMID 29555836, PMID 31690104, PMID 31883339, PMID 35041482, PMID 38710669, PMID 42636950, PMID 12831818, PMID 24678937, PMID 27040324, PMID 31525069, PMID 32774184, PMID 34581194, PMID 35321859, PMID 35595203, PMID 35656983, PMID 36515976, PMID 16980116, PMID 20096533, PMID 20188503, PMID 20566953, PMID 21273254, PMID 22424519, PMID 22443479, PMID 23349346, PMID 24621999, PMID 24657695, PMID 25533774, PMID 25655063, PMID 25788234, PMID 26139739, PMID 26384204, PMID 26436963, PMID 26491110, PMID 26896466, PMID 27601429, PMID 27609682, PMID 27815101, PMID 28279376, PMID 28306757, PMID 28321003, PMID 28527771, PMID 28912187, PMID 29171730, PMID 29912142, PMID 29914867, PMID 30031719, PMID 30250733

NIH funding

2023 (9), 2019 (6), 2015 (2), 2025 (2), R01AG089981 (2), R21HL150373 (2), 1RC1LM010526 (1), 2009 (1), 2016 (1), 2017 (1), 2018 (1), 268201000048C-5-0-1 (1), K23HL004444 (1), K23HL078901 (1), K23HL136902 (1)